Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm NCT06987383

Vibegron for ENergy Thinking and Resilience in Aging (VENTURA)

Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity

Sponsor: National Institute on Aging (NIA)

Conditions Obesity

Updated 3 times since 2025 Last updated: Feb 20, 2026 Started: Aug 31, 2026 Primary completion: Jul 31, 2028 Completion: Jul 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06987383, this PHASE3 trial focuses on Obesity and remains actively recruiting participants. Sponsored by National Institute on Aging (NIA), it has been updated 3 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Feb 2026 — Present [monthly]

Not Yet Recruiting PHASE3
Aug 2025 — Feb 2026 [monthly]

Not Yet Recruiting PHASE3
Jun 2025 — Aug 2025 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Aging (NIA)
Wake Forest University Health Sciences

Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winston-Salem, United States